Transforming growth factor-β1 and its receptors in patients with ulcerative colitis
Authors:
- Antoni StadnickiASAntoni Stadnicki
- Grzegorz MachnikGMGrzegorz Machnik
- Ewa Klimacka-NawrotEKEwa Klimacka-Nawrot
- Anna Wolanska-KarutAWAnna Wolanska-Karut
- Krzysztof LabuzekKLKrzysztof Labuzek
- 1 June 2009
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 9 (6) , 761-766
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammationInflammatory Bowel Diseases, 2007
- Inflammatory bowel disease: cause and immunobiologyThe Lancet, 2007
- A Meta-Analysis of Antibiotic Therapy for Active Ulcerative ColitisDigestive Diseases and Sciences, 2007
- Growth Factors as Treatment Options for Intestinal InflammationAnnals of the New York Academy of Sciences, 2006
- Alterations in Antioxidant Power and Levels of Epidermal Growth Factor and Nitric Oxide in Saliva of Patients with Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2004
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel diseaseJournal of Clinical Investigation, 2001
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrityCytokine & Growth Factor Reviews, 1997
- Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrateAnnals of Hematology, 1989